Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
Adrenal, ALK, Anaplastic, Android, Antitrust, Apple, appraisal, arbitration, ASC, Atopobiumvaginae, Ballard, birth, boceprevir, Bologna, break, broadest, Bryant, Cayman, Cellmark, Chancery, children, Chlamydia, climate, CN, companywide, compelling, County, covenant, created, creating, Crizotinib, customary, DDC, Debra, decree, Delaware, digital, displayed, divest, divestiture, driver, duty, EMR, enjoin, exaggerated, exceed, export, factual, Fargo, fast, fastest, fiduciary, FISH, Friday, glabrata, gold, Gonorrhea, grandfather, Grassley, Greenberg, HSR, HSV, Hyperplasia, Hypogonadal, INCIVEK, indeterminate, Japan, Kinase, Kingdom, Kletzel, LabCorpBeacon, LEAN, Lender, lending, Locke, logo, Lymphoma, melanoma, men, Mercer, metastatic, MIPPA, mission, molecule, mutually, myelodysplastic, Nannetti, nationwide, neutral, NPT, NuSwabSM, Orchid, overtime, paternity, Peggy, pillar, pilot, political, portal, postpone, Powell, pre, pregnancy, prescribe, Probe, prolonged, prosper, protease, proven, qualitative, repaid, repatriation, repayment, RET, Reveal, Rivera, satellite, satisfactory, sequestration, sexually, shareholder, SHOX, Silverberg, simple, situated, SMA, sought, Southern, specialist, speeding, staffing, stature, stayed, steroid, strictly, subset, substantive, suit, suite, Swing, Syndication, TC, telaprevir, tender, tendered, testosterone, throughput, TouchTM, transparency, TX, uniparentaldisomy, UnitedHealth, unrest, unsupported, unused, vemurafenib, ViroMed, wage, West, women, XALKORI, Zelboraf
Removed:
Accountant, acquiring, addressable, addressed, addressing, announcement, appealed, Arranger, attribute, begin, bioanalytical, biotechnology, Bookrunner, bradford, Chairman, CKD, collectively, Colorado, commenced, communicating, communication, composition, conflict, Controller, declaratory, decreasing, delivering, designating, detach, discovery, dividend, divisional, doctor, drafting, easily, enrollee, entitle, EVP, excluded, expect, exploring, favor, Fort, immunoanalytical, implementing, infringement, initiated, insider, inventory, listing, locator, measure, measuring, Metabolite, owner, planning, post, preclinical, preservation, redeemed, relation, remanded, remitted, rest, safeguard, specification, succession, tailor, Tandem, Trust, turn, undertaken, unreduced, workforce
Filing tables
Filing exhibits
- 10-K Annual report
- 10.31 Credit Agreement
- 12.1 Ratio of Earnings to Fixed Charges
- 21 List of Subsidiaries
- 23.1 Consent of Pricewaterhousecoopers
- 24.1 Power of Attorney
- 24.2 Power of Attorney
- 24.3 Power of Attorney
- 24.4 Power of Attorney
- 24.5 Power of Attorney
- 24.6 Power of Attorney
- 24.7 Power of Attorney
- 24.8 Power of Attorney
- 24.9 Power of Attorney
- 31.1 Certification of CEO
- 31.2 Certification of CFO
- 32 Written Statement CEO and CFO
Related press release
LH similar filings
Filing view
External links
Exhibit 32
Written Statement of
Chief Executive Officer and Chief Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)
The undersigned, the Chief Executive Officer and the Chief Financial Officer of Laboratory Corporation of America Holdings (the “Company”), each hereby certifies that, to his knowledge on the date hereof:
(a) the Form 10-K of the Company for the Period Ended December 31, 2011 filed on the date hereof with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(b) information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| By: | /s/ DAVID P. KING | |
| David P. King | ||
| Chief Executive Officer | ||
| February 23, 2012 | ||
| By: | /s/ WILLIAM B. HAYES | |
| William B. Hayes | ||
| Chief Financial Officer | ||
| February 23, 2012 | ||